|
KCTD18 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.031700E-04 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.553200E-04 |
| Normal-vs-Stage2 |
4.245200E-01 |
| Normal-vs-Stage3 |
2.011500E-02 |
| Normal-vs-Stage4 |
3.081600E-02 |
| Stage1-vs-Stage2 |
2.862800E-01 |
| Stage1-vs-Stage3 |
8.099800E-01 |
| Stage1-vs-Stage4 |
6.677600E-01 |
| Stage2-vs-Stage3 |
2.930600E-01 |
| Stage2-vs-Stage4 |
2.620000E-01 |
| Stage3-vs-Stage4 |
7.997800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.044300E-04 |
| Normal-vs-AfricanAmerican |
1.048260E-02 |
| Normal-vs-Asian |
2.937200E-01 |
| Caucasian-vs-AfricanAmerican |
9.017800E-01 |
| Caucasian-vs-Asian |
9.052000E-01 |
| AfricanAmerican-vs-Asian |
9.400800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.06749999999145E-05 |
| Normal-vs-Female |
4.070000E-01 |
| Male-vs-Female |
1.187550E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.995800E-04 |
| Normal-vs-Extreme_Weight |
2.25259999997451E-06 |
| Normal-vs-Obese |
2.722100E-02 |
| Normal-vs-Extreme_Obese |
4.058200E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.551400E-01 |
| Normal_Weight-vs-Obese |
2.438800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.695800E-01 |
| Extreme_Weight-vs-Obese |
8.271600E-02 |
| Extreme_Weight-vs-Extreme_Obese |
2.504800E-01 |
| Obese-vs-Extreme_Obese |
8.405400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.609000E-01 |
| Normal-vs-Age(41-60Yrs) |
2.678400E-02 |
| Normal-vs-Age(61-80Yrs) |
7.78580000000417E-05 |
| Normal-vs-Age(81-100Yrs) |
2.393000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.230200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.412300E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.162800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.987600E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.951200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.235800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
1.156890E-03 |
| Normal-VS-Type2 PRCC |
2.159000E-03 |
| Normal-VS-KIRP CIMP |
1.161030E-01 |
| Normal-VS-Unclassified PRCC |
7.705200E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.319800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.183200E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.088010E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.057800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
7.574200E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
2.586200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.570600E-04 |
| Normal-vs-N1 |
2.261000E-01 |
| Normal-vs-N2 |
1.086100E-02 |
| N0-vs-N1 |
3.825200E-01 |
| N0-vs-N2 |
6.734600E-01 |
| N1-vs-N2 |
5.108200E-01 |
|
|
